Clinical Evaluation of the Safety and Efficacy of a New Multifocal Contact Lens
This study has been completed.
Sponsor:
Alcon Research
Information provided by (Responsible Party):
Alcon Research
ClinicalTrials.gov Identifier:
NCT01797783
First received: February 21, 2013
Last updated: April 25, 2014
Last verified: April 2014
- Full Text View
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study was to demonstrate substantial equivalence of the new DAILIES® AquaComfort Plus® Multifocal (DACP MF) contact lens to the commercially available Focus® DAILIES® Progressives (FDP) contact lens.
| Condition | Intervention |
|---|---|
|
Myopia Ametropia Presbyopia Refractive Error |
Device: Nelfilcon A multifocal contact lens with comfort additive Device: Nelfilcon A multifocal contact lens |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Subject) Primary Purpose: Treatment |
| Official Title: | Clinical Evaluation of the Safety and Efficacy of a New Multifocal Contact Lens |
Resource links provided by NLM:
Further study details as provided by Alcon Research:
Primary Outcome Measures:
- Subjective Overall Vision [ Time Frame: Up to Day 30 ] [ Designated as safety issue: No ]The participant was instructed to, "Please rate the aggregate of distance, intermediate, and near vision quality. Fill in the circle below the number that indicates your selection. Rate eyes together, marking only 1 circle for both eyes. Higher numbers mean better vision." The response was recorded on a continuous scale from 1-10 (1=poor, 10=excellent).
Secondary Outcome Measures:
- Binocular Snellen Visual Acuity (VA) at Distance With Study Lenses [ Time Frame: Up to Day 30 ] [ Designated as safety issue: No ]Visual Acuity was tested while reading a chart at 20-foot equivalent distance from the participant with both eyes together. The Snellen fraction compares the participant's result to the result expected from the 'normal' visual system. The numerator represents the distance between the participant and the chart, and the denominator represents the distance at which a person with 'normal' vision would be able to discern the same letter size. 20/20 is considered to be 'normal' vision, whereas visual acuity of 20/40 means the participant is able to read a certain size letter 20 feet away that a person with 'normal' vision would be able to read from 40 feet away. A larger denominator, therefore, indicates a lower visual acuity.
- Binocular Snellen Visual Acuity (VA) at Near (40cm) With Study Lenses [ Time Frame: Up to Day 30 ] [ Designated as safety issue: No ]Visual Acuity was tested while reading charts at a distance of 40 cm from the participant with both eyes together. The Snellen fraction 20/20 represents 'normal' near vision. A larger denominator indicates a lower visual acuity.
| Enrollment: | 83 |
| Study Start Date: | February 2013 |
| Study Completion Date: | April 2013 |
| Primary Completion Date: | April 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: DAILIES® AquaComfort Plus® Multifocal
Nelfilcon A multifocal contact lens with comfort additive worn for 30 days on a daily wear, daily disposable basis
|
Device: Nelfilcon A multifocal contact lens with comfort additive |
|
Active Comparator: Focus® DAILIES® Progressives
Nelfilcon A multifocal contact lens worn for 30 days on a daily wear, daily disposable basis
|
Device: Nelfilcon A multifocal contact lens |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Sign Informed Consent Document.
- Presbyopic and require a spectacle add of up to and including 3.00 diopters (D).
- Currently wear soft contact lenses.
- Willing and able to wear multifocal contact lenses in both eyes within the available range of powers for this trial and comply with the wearing and replacement schedule.
- Manifest cylinder less than or equal to 1.00 D.
- Able to achieve best corrected visual acuity (BCVA) of 20/25 or better (Snellen) in each eye at distance (as determined by manifest refraction).
- Able to achieve distance visual acuity of 20/40 (Snellen) or better in each eye with study lenses and deem subjective vision as satisfactory at time of dispense.
- Other protocol-defined inclusion criteria may apply.
Exclusion Criteria:
- Any anterior segment infection, inflammation, disease, or abnormality that contraindicates contact lens wear within 6 months prior to enrollment.
- Any use of systemic or ocular medications for which contact lens wear could be contraindicated.
- History of corneal or refractive surgery.
- Biomicroscopy findings greater than Grade 2 at baseline.
- A pathologically dry eye that precludes contact lens wear.
- Monocular (only one eye with functional vision).
- Wear habitual contact lenses on an extended wear schedule (any number of nights of overnight wear on a regular basis).
- History of intolerance or hypersensitivity to any component of the investigational products.
- Concurrent participation in a contact lens or contact lens care product clinical trial or within the previous 30 days.
- Eye injury or ocular or intra-ocular surgery within 6 months prior to enrollment.
- Other protocol-defined exclusion criteria may apply.
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01797783
Please refer to this study by its ClinicalTrials.gov identifier: NCT01797783
Sponsors and Collaborators
Alcon Research
Investigators
| Study Director: | Justin Webb, O.D. | Alcon Research |
More Information
No publications provided
| Responsible Party: | Alcon Research |
| ClinicalTrials.gov Identifier: | NCT01797783 History of Changes |
| Other Study ID Numbers: | C-12-054 |
| Study First Received: | February 21, 2013 |
| Results First Received: | April 25, 2014 |
| Last Updated: | April 25, 2014 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Alcon Research:
|
Myopia Presbyopia Refractive error Contact lenses Multifocal |
Additional relevant MeSH terms:
|
Refractive Errors Eye Diseases |
ClinicalTrials.gov processed this record on March 03, 2015